|
Complete Genomics, ISB To Collaborate on Genome Studies; Firm Targets $5K Genome for 2009 (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Oct 6, 2008)
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract (PR Newswire via Yahoo! Finance)
Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases , a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers.
(Oct 6, 2008)
Complete Genomics launches, becomes world's first large-scale human genome sequencing company (EurekAlert!)
( Complete Genomics ) Complete Genomics launched today as the world's first provider of large-scale human genome sequencing services. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. It ...
(Oct 6, 2008)
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract (CNW Group via Yahoo! Finance)
Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases , a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers.
(Oct 6, 2008)
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract (PR Newswire via Yahoo! Finance)
Caprion Proteomics Inc. announced today that it has been awarded a US$12.9 million contract by the National Institute of Allergy and Infectious Diseases , a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers.
(Oct 6, 2008)
Signature Genomic Laboratories Announces Appointment of New Laboratory Director (Centre Daily Times)
Signature Genomic Laboratories has appointed Roger Schultz, Ph.D., as Laboratory Director.
(Oct 6, 2008)
New Tech Could Change Genetic Research (ABC News)
A new genome-sequencing service could change the face of human genomics.
(Oct 6, 2008)
Saliva Proteins May Help Spot Oral Cancer (MedicineNet.com)
Title: Saliva Proteins May Help Spot Oral Cancer Category: Health News Created: 10/4/2008 2:00:00 AM Last Editorial Review: 10/6/2008
(Oct 6, 2008)
Complete Genomics emerges from stealth (BizJournals)
Third-generation human genome sequencing company Complete Genomics Inc. announced its launch on Monday. (DNA)
(Oct 6, 2008)
Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger (Business Wire via Yahoo! Finance)
CARLSBAD, Calif. & FOSTER CITY, Calif.----Invitrogen Corporation and Applied Biosystems Inc. today announced that RiskMetrics Group, formerly known as Institutional Shareholder Services, or ISS, Glass Lewis & Co. and PROXY Governance, Inc., have all recommended that Invitrogen and Applied Biosystems shareholders vote FOR the proposed merger at each company's respective special meeting of ...
(Oct 6, 2008)
Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger (Centre Daily Times)
Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that RiskMetrics Group, formerly known as Institutional Shareholder Services, or ISS, Glass Lewis & Co. and PROXY Governance, Inc., have all recommended that Invitrogen and Applied Biosystems shareholders vote FOR the proposed merger at each company's respective special meeting of shareholders.
(Oct 6, 2008)
Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention (PR Newswire via Yahoo! Finance)
The Nobel Prize-winning discovery of the causal link between human papillomavirus and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer globally.
(Oct 6, 2008)
$5,000 genome next year, company promises (Nature)
Complete Genomics is about to release fast, cheap sequencing into a competitive market.
(Oct 6, 2008)
Ronald Mirman: U.S. Space Policy = Waste As Much Money As Possible (HuffingtonPost)
Both Barack Obama and John McCain have spoken on space policy, and both are wrong. McCain is clearly more interested (he was a pilot and...
(Oct 7, 2008)
New Self-training Gene Prediction Program For Fungi Developed (Science Daily)
Researchers have developed a computer program that trains itself to predict genes in the DNA sequences of fungi. The software will be freely available for academic researchers.
(Oct 7, 2008)
LSUS program targets movie production (The Shreveport Times)
A new animation and visual effects program aims to train a workforce of digital media artists for work on movies, TV projects and videogames. The program's supported by $800,000 in state money.
(Oct 7, 2008)
Researchers working on cancer detection blood test (Tucson Citizen)
Researchers are working on a simple blood test to detect cancer a year before symptoms develop.
(Oct 7, 2008)
Links (EUActiv)
The challenges are identified in a draft strategic plan outlining the agency's work for the next five years.
(Oct 7, 2008)
Enza Chooses Fluidigm BioMark System to Help Assure Core Seed Quality (Centre Daily Times)
Fluidigm Corporation and BIOKE, a licensed distributor for the company, today announced that Enza Zaden, one of the world's leading suppliers of high-quality vegetable seeds for agriculture, has chosen the Fluidigm's BioMark(TM) System for Genetic Engineering and the new 96.96 Dynamic Array to help assure the quality of its seed supply.
(Oct 7, 2008)
So, CTO, who's your Sarah Palin or Joe Biden? (InfoWorld via Yahoo! News)
Even in the nuts-and-bolts world of tech execs, choosing a right-hand man (or woman, of course) can be as politically challenging as anything going on in the halls of Washington, D.C.
(Oct 7, 2008)
Isilon CTO Addresses Life Science Data Storage Challenges at Harvard Medical School's BioMedical HPC Leadership Summit (PR Newswire via Yahoo! Finance)
Isilon® Systems , the leader in clustered storage, today announced that Isilon Chief Technology Officer Paul Rutherford will address the growing data storage challenges facing life science research organizations as part of the Harvard Medical School's BioMedical HPC Leadership Summit, October 5-7, in Cambridge, Massachusetts.
(Oct 7, 2008)
AsiaNet Daily Summary - Press Releases for Tuesday, Oct. 7, 2008 (Thaipr.net)
Çѹ·Õè 7 µØÅÒ¤Á 2551 17:10 ¹. SURRENDA-LINK... CHESTER - Surrenda-link Investment Management, Europe's premier traded life policy investment specialist(1), has received soaring levels of enquiries from institutional investors regarding US Life Settlement investments.
(Oct 7, 2008)
SQI Diagnostics Announces Appointment of Senior VP, Sales and Marketing (PR Newswire via Yahoo! Finance)
SQI Diagnostics Inc. , a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that Thomas O'Connor has been appointed the Company's Senior Vice President, Sales and Marketing.
(Oct 7, 2008)
Roche NimbleGen Multiplex CGH Arrays Enable Detection of Exonic Deletions and Duplications Associated with Muscular ... (Business Wire via Yahoo! Finance)
MADISON, Wis----Researchers from France investigating DNA copy number changes associated with genetic disorders have reported the development and validation of a Roche NimbleGen CGH multiplex, microarray-based research method for detecting genomic deletions and duplications at high-resolution.
(Oct 7, 2008)
MDRNA, Inc. Advances RNAi Pipeline With Selection of Lead Candidate for Hypercholesterolemia Program (Marketwire via Yahoo! Finance)
MDRNA, Inc. announced today that it has advanced its RNAi pipeline with the selection of a Lead Candidate in its hypercholesterolemia program targeting Apolipoprotein B. The compound, designated MDR-04227, was developed using MDRNA's propriety drug discovery engine, which is built on a broad and enabling intellectual property estate and an in-house novel and proprietary delivery technology.
(Oct 7, 2008)
South African Core Lab Adopts Affymetrix Technology for Genomic Studies (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Affymetrix Inc., today announced that one of South Africa’s largest public core labs has begun offering genomic research on the Affymetrix GeneChip® platform.
(Oct 7, 2008)
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies (Business Wire via Yahoo! Finance)
FORT WASHINGTON, Pa.----The National Comprehensive Cancer Network , Abraxis BioScience , and AstraZeneca today announced that they have entered into a collaboration to conduct multiple investigator-initiated studies of Abraxis BioScience's anti-cancer drug ABRAXANE® for Injectable Suspension , which is based on the company's proprietary tumor targeting technology known as the nab™ platform.
(Oct 7, 2008)
Invitrogen Files Merger Notification With European Commission (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Invitrogen Corporation today announced that it has filed the necessary formal notification to the European Commission with respect to its pending acquisition of Applied Biosystems Inc. .
(Oct 7, 2008)
CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of ... (PR Newswire via Yahoo! Finance)
CEL-SCI Corporation announced today that it has entered into a Material Transfer Agreement with the National Institutes of Health Clinical Center and the laboratory of Dr. Francesco M.
(Oct 7, 2008)
South Africa's CPGR Begins Offering Services Using Affymetrix Microarray Platform (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Oct 7, 2008)
UB tapped for HIV/AIDS work (Business First of Buffalo)
The University at Buffalo has received a new $7.6 contract that will help enable high quality clinical trials for HIV/AIDS researchers around the world.
(Oct 7, 2008)
Arrayit - BSI Alliance Provides New Research Technology to Identify Disease Diagnostics (Marketwire via Yahoo! Finance)
Integrated Media Holdings, Inc. announced today that its wholly owned subsidiary, TeleChem International, Inc. doing business as Arrayit Company, has entered into an exclusive agreement with BioSystems International SAS for the supply and license rights to produce state-of-the-art microarrays featuring antibodies that identify proteins uniquely expressed in human plasma. The Human Plasma ...
(Oct 7, 2008)
Company To Sequence 1,000 Human Genomes In 2009 For $5,000 Each (Medical News Today)
Complete Genomics Inc., a third-generation human genome sequencing company, has announced its formal launch as the world's first provider of large-scale human genome sequencing services. The company, which was established in March 2006, has been operating in "stealth mode" from a 32,000-square-foot facility near San Francisco.
(Oct 7, 2008)
Telechem, BioSystems International to Collaborate on Proteome Microarray (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Oct 7, 2008)
So, CTO, Who's Your Sarah Palin or Joe Biden? (PC World)
For IT, the choice of a deputy matters a great deal. So how do you get the right one?
(Oct 7, 2008)
Enza Zaden chooses Fluidigm BioMark system to help assure core seed quality (SeedQuest)
Fluidigm Corporation and BIOKÉ , a licensed distributor for the company, today announced that Enza Zaden , one of the world’s leading suppliers of high-quality vegetable seeds for agriculture, has chosen the Fluidigm’s BioMark™ System for Genetic Engineering and the new 96.96 Dynamic Array to help assure the quality of its seed supply.
(Oct 7, 2008)
UB Receives $7.6 Million Grant (WGRZ-TV Buffalo)
The University at Buffalo is receiving a multi-million dollar contract in the worldwide fight against HIV and Aids. Details of the contract were released Tuesday morning at the Center for Excellence in Bioinformatics and Life Sciences.
(Oct 8, 2008)
Caprion wins $12.9 million biomarker research contract from NIAID (Pharmaceutical Business Review)
Caprion Proteomics, a provider of proteomics based services to the pharmaceutical industry, has received a $12.9 million contract form the National Institute of Allergy and Infectious Diseases, a part of the US National Institutes of Health, to carry out biodefense research in the area of infectious disease biomarkers.
(Oct 8, 2008)
RO 5.2m Genetic Centre coming up at Bausher (Zawya)
08 October 2008 MUSCAT -- The RO 5.2 million National Genetic Centre (NGC) coming up at Bausher Wilayat near Royal Hospital will enable the Ministry of Health to extend the potential health benefits of the genomics advances to people.
(Oct 8, 2008)
Nonlinear Dynamics' Progenesis analysis software is chosen by Boston University's Cardiovascular Proteomics Center ... (Business Wire via Yahoo! Finance)
NEWCASTLE UPON TYNE, England----Nonlinear Dynamics Ltd, the world leading developer of analysis solutions for proteomics and biomarker discovery, has announced that Boston University's Cardiovascular Proteomics Center Core Laboratory have chosen the Progenesis software range for their label free LC-MS and 2D data analyses.
(Oct 8, 2008)
Complete Genomics and ISB form partnership (Pharmaceutical Business Review)
Complete Genomics, a newly launched, third-generation human genome sequencing company, and the Institute for Systems Biology have announced their partnership to conduct populationwide human genome studies.
(Oct 8, 2008)
Webcast On CombiMatrix's Comprehensive Cancer Array Available On Website (GlobeNewswire via Yahoo! Finance)
MUKILTEO, Wash., Oct. 8, 2008 -- CombiMatrix Corporation held a web-broadcast on October 7, 2008 to discuss its development of a Comprehensive Cancer Array test for the non-invasive screening of multiple cancers simultaneously.
(Oct 8, 2008)
CEL-SCI Enters Agreement With National Institutes Of Health Clinical Center To Determine The Molecular Basis Of ... (Medical News Today)
CEL-SCI Corporation (NYSE: CVM) announced that it has entered into a Material Transfer Agreement (MTA) with the National Institutes of Health Clinical Center (NIHCC) and the laboratory of Dr. Francesco M. Marincola, M.D., to investigate the molecular basis of changes to the tumor microenvironment caused by CEL-SCI's cancer drug Multikine. Dr.
(Oct 8, 2008)
UK PubMed goes beyond journals (vnunet.com)
Tracey Caldwell, Best known as an access gateway to biomedical research journals, the UK incarnation of the PubMed Central website is to introduce access to additional types of content, such as clinical...
(Oct 8, 2008)
UB awarded grant to fight against global AIDS epidemic (The Buffalo News)
Buffalo will play a vital international role in the fight against the global AIDS epidemic.
(Oct 8, 2008)
Invitrogen Redesigns GIBCO(R) Bottle to Improve Form and Function (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, announced the global launch of its updated GIBCO cell culture media bottles.
(Oct 8, 2008)
Searching for Intelligence in Our Genes (Scientific American)
In Robert Plomin’s line of work, patience is essential. Plomin, a behavioral geneticist at the Institute of Psychiatry in London, wants to understand the nature of intelligence. As part of his research, he has been watching thousands of children grow up. Plomin asks the children questions such as “What do water and milk have in common?” and “In what direction does the sun set?” At first he and ...
(Oct 8, 2008)
New Lab Manual Focuses On Essential Methods For Purifying And Characterizing Proteins (Medical News Today)
A new, user-friendly laboratory manual for protein purification and analysis has just been released by Cold Spring Harbor Laboratory Press.
(Oct 8, 2008)
Pathwork Diagnostics Announces Key Additions to Management Team (PR Newswire via Yahoo! Finance)
Pathwork Diagnostics, a molecular diagnostics company focused on oncology, announced today the appointment of two key positions within the company's management team, Fletcher Payne as Chief Financial Officer and Mark McDonough as Vice President of US Sales.
(Oct 8, 2008)
Boston U Proteomics Lab Using Nonlinear Dynamics' Analysis Software (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Oct 8, 2008)
|
